Cervical Cancer Vaccine Risks
A large percentage of women admit to living in fear of the big C, however cervical or breast cancer free women admit that the thought of contacting the disease never leaves their thoughts.
Sadly, self breast examination seems to be unimportant for some women who choose to ignore a health issue as vital to secure their well being, ignoring any indication that breast cancer is developing can result in the patient having to fight for their life. If an examination of the breasts had taken place in some unfortunate cases the whole scenario would have just involved treating the breast cancer and no involvement of an undertaker. Women need to wise up because if they continue to carry ignorance as an ally to help beat this battle – then they lose. Winning includes modern medicines. Early cancer treatment betters survival odds hence giving a patient the chance to carry on with their life instead of throwing it away.
Aside from bosom blunders where ignorance may have prevailed we have cervical cancer. Women need to be aware of all involvements i.e. what to expect throughout any cervical cancer treatments. The cervix is the lower part of the womb or uterus and is commonly referred to as the ‘neck of the womb’.
The cervix and its purpose are to help maintain a normal pregnancy. In non-pregnant women, the cervix has no obvious function. In the UK cervical cancer is down on paper as the sixth most common cancer in women. It is of the utmost importance for a woman to keep healthy in mind body and soul by having regular cervical cancer smear tests – oft times referred to as a Pap smear test. Smear tests are commonly carried out in order to detect any cell changes that come before cancer. It’s a waiting game, meaning, it can take years for these cell changes detected at the time of a cervical smear test to become cancer. Luckily some changes have been known to go away by themselves.
Lung Cancer Secrets Revealed Click here
Women who waited in anticipation for their cancer results said they found it more of an ordeal coping with the wait than that of receiving the actual prognosis (cervical cancer).
Suffering in silence is not healthy, not all abnormal test results indicate that cervical cancer is present. It is through early diagnosis and treatment of pre-cancerous changes that development of actual cancer can be prevented. Early detection is most profound to help fight the disease.
There are two types of this cancer; the squamous cell cancer and aden-ocarcinoma. Cervical smear tests detect the early changes of squamous cell cancer. Early stage growths of certain cancers can be treated with surgery or radiotherapy thus resulting in a cure.
Regular questions asked about cervical cancer are what the causes are; well there is no definite single cause, however study points the finger at a viral infection of the cervix or cancer sticks (cigarettes). Fags are a major health hazard relating to lung cancer, smoking is said to also increase the risk of developing cervical cancer and even the number of partners in youth trial runs of intercourse have also been linked to being connected to the cause. In the UK cervical tests are routinely performed every three years, lives are being saved because of this.
Females face a silent but deadly situation because; pre-cancerous changes of the cervix that show up on cervical smear tests unfortunately do not give symptoms. Undergoing a biopsy of the cervix is the way cervical cancer is diagnosed. The process is normally done with an internal examination called a colposcopy.
Treating cancer of the cervix will purely depend upon the severity of the disuse, meaning, has it spread to the pelvis. A radical hysterectomy or Wertheim’s hysterectomy may be suggested as treatment. It is at this stage that a specialist gynaecologist will conduct surgery. Radiotherapy destroys tumour cells that the gynaecologist cannot see.
Remember “out of sight out of mind”, is not a healthy approach for a cure; a healthy approach is to keep it in mind and any cervical cancer symptoms must be kept in sight.
lung cancer treatment breakthroughs Click here
Categories: Breast Cancer Questions & Answers Tags: cancer, cervical, Risks, vaccine
Health news: Liquorice soothes the symptoms of eczema, a vaccine to quit smoking and hypnosis to beat cancer pain
Health news: Liquorice soothes the symptoms of eczema, a vaccine to quit smoking and hypnosis to beat cancer pain
In our round-up of health news this week, sweets that soothe eczema symptoms, an anti-smoking vaccine and how hypnosis can ease cancer pain.
Read more on Daily Mail
Categories: Breast Cancer Pain Tags: beat, cancer, eczema, health, Hypnosis, Liquorice, News, pain, quit, smoking, soothes, Symptoms, vaccine
Research on cancer vaccine begins to pay off
Research on cancer vaccine begins to pay off
The vaccine that Larry Mathews is getting won’t protect him from the flu. That’s OK — the stakes are far higher than that.
Read more on PhysOrg
Categories: Breast Cancer Tumor Tags: Begins, cancer, research, vaccine
Vaccine Proves to be Efficient in Treating Prostate Cancer
Since in US, more than 200,000 new cases of prostate cancer are discovered every year a more effective treatment was desperately needed.
At the prostate cancer symposium in Orlando, co-sponsored by the American Society of Clinical Oncology, Eric J. Small, MD, UCSF professor of medicine and urology presented the findings of the study he led helped by other 19 US institutions, regarding an effective treatment for prostate cancer.
Scientists said that the rate of survival increased by four and a half months in those who were administered the cancer vaccine compared with those who got the placebo.
For the patients this is great news because it gives them hope that an even better vaccine could be discovered. This vaccine is not like the others that are designed to prevent a disease. This is made to treat advanced prostate cancer by increasing the immune system’s response to cancer cells.
The vaccine was well tolerated by patients and the side effects were mild: fever and chills. This is good news because chemotherapy and radiation gives a lot of unbearable side effects.
Small included in the study 127 patients suffering of asymptomatic metastatic hormone refractory prostate cancer (HRPC). 82 of them received the vaccine and 45 got placebo. They were administered three shots over six weeks. The treatment continued three years.
For those treated with the vaccine, the median rate of survival was 25.9 months. For those who got a placebo treatment, the overall of survival was 21.4 months.
The conclusions were that 115 patients of this group had progressive disease at the time of data analysis and all patients were followed for survival for 3 years.
Scientists do not know if the vaccine will work on patients suffering of early-stage prostate cancer and of explosive terminal cancer. The vaccine, called Provenge, does not cure cancer but at least it slows it down.
Other cancer vaccines are being developed for treating: leukemia, breast cancer, colon cancer, and kidney and pancreas cancer as well.
The human body is not able to recognize the cancer cells and that is why it can not fight them without help. The vaccine is designed to alert the body is cancerous cells are present. Provenge has been made out of a genetically engineered protein and a dendritic cell provided from the patient’s bloodstream. After getting the vaccine shots, the immune system will react and will activate immune T-cells to find and destroy the cancer cells.
This discovery is important not only for those who suffer of the disease but also for the field. This vaccine confirms what everybody denied, that vaccines can really work.
For more information about prostate cancer and about prostate cancer treatment please review this web site http://www.prostate-cancer-center.com
Novartis Vaccines Begins Shipment of Seasonal Influenza Vaccine Fluvirin(R) to U.S. Market to Help Protect Ahead of …
Novartis Vaccines Begins Shipment of Seasonal Influenza Vaccine Fluvirin(R) to U.S. Market to Help Protect Ahead of …
CAMBRIDGE, MA–(Marketwire – July 29, 2010) – Novartis Vaccines ( NYSE : NVS )
Read more on Marketwire
